Genetic epidemiology with a Capital E, ten years after

Genetic Epidemiology

Volumn 35, Issue 8, 2011, Pages 845-852

  Khoury, Muin J ^a   Gwinn, Marta ^a   Clyne, Mindy ^a   Yu, Wei ^a  

^a NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

Biology; Epidemiology; Genetics; Genomics; Informatics; Medicine; Public health

Indexed keywords

ARTICLE; BIOINFORMATICS; GENE INTERACTION; GENE SYNTHESIS; GENETIC ANALYSIS; GENETIC DISORDER; GENETIC EPIDEMIOLOGY; GENOME; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; MEDICAL LITERATURE; RETINA MACULA AGE RELATED DEGENERATION;

DATABASES, GENETIC; GENE-ENVIRONMENT INTERACTION; GENETICS, POPULATION; GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MACULAR DEGENERATION; MOLECULAR EPIDEMIOLOGY; PUBLIC HEALTH;

EID: 82355161521     PISSN: 07410395     EISSN: 10982272     Source Type: Journal    
DOI: 10.1002/gepi.20634     Document Type: Article

References (67)

1. Age-Related Eye Disease Study Research Group. 2001. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 119:1417-1436.
2. Ahrens W, Krickeberg K, Pigeot I. 2005. Introduction to epidemiology. In: Ahrens W, Pigeot I, editors. Handbook of Epidemiology. Berlin, Germany: Springer. p 1-42.
3. Allen NC, Bagade S, McQueen MB, Ioannidis JP, Kavvoura FK, Khoury MJ, Tanzi RE, Bertram L. 2008. Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the szgene database. Nat Genet 40:827-834.
4. Botkin JR, Teutsch SM, Kaye CI, Hayes M, Haddow JE, Bradley LA, and EGAPP Working Group. 2010. Outcomes of interest in evidence-based evaluations of genetic tests. Genet Med 12:228-235.
5. Bookman EB, McAllister K, Gillanders E, Wanke K, Balshaw D, Rutter J, Reedy J, Shaughnessy D, Agurs-Collins T, Paltoo D, Atienza A, Bierut L, Kraft P, Fallin MD, Perera F, Turkheimer E, Boardman J, Marazita ML, Rappaport SM, Boerwinkle E, Suomi SJ, Caporaso NE, Hertz-Picciotto I, Jacobson KC, Lowe WL, Goldman LR, Duggal P, Gunnar MR, Manolio TA, Green ED, Olster DH, Birnbaum LS; for the NIH G × E Interplay Workshop participants. 2011. Gene-environment interplay in common complex diseases: forging an integrative model-recommendations from an NIH workshop. Genet Epidemiol Feb 11, ahead of print.
6. Centers for Disease Control and Prevention: the Human Genome Epidemiology Network (HuGENet). 2011. Accessed online June 15, 2011 at:
7. Charbel Issa P, Chong NV, Scholl HP. 2011. The significance of the complement system for the pathogenesis of age-related macular degeneration-current evidence and translation into clinical application. Graefes Arch Clin Exp Ophthalmol 249:163-174.
8. Collins FC, Green ED, Guttmacher AE, Guyer MS. 2003. A vision for the future of genomics research. Nature 422:835-847.
9. Congdon N, O'Colmain B, Klaver CC, Klein R, Muñoz B, Friedman DS, Kempen J, Taylor HR, Mitchell P; Eye Diseases Prevalence Research Group. 2004. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol 122:477-485.[PMID: 15078675]
10. Dolan SM, Holleegard MV, Merialdi M, Bertran AP, Allen T, Abelow C, Nace J, Lin BK, Khoury MJ, Ioannidis JP, Bagade S, Zheng X, Dubin RA, Bertram L, Velez Edwards DR, Menon R. 2010. Synopsis of preterm birth genetic association studies: the preterm birth genetics knowledge base. Publ Health Genom 13:514-523.
11. Evaluation of Genomic Applications in Practice and Prevention. 2011. Accessed online June 15, 2011 at:
12. Evaluation of Genomic Applications in Practice and Prevention Working Group. 2010. Genomic profiling to assess cardiovascular risk to improve cardiovascular health. Genet Med 12:839-843.
13. Evaluation of Genomic Applications in Practice and Prevention Working Group. 2011. Routine testing for factor V Leiden (R506Q) and prothrombin mutations (20210G>A) in adults with a history of idiopathic venous thromboembolism and their adult relatives. Genet Med 13:67-78.
14. Food and Drug Administration. 2011. Table of Pharmacogenomic Biomarkers in Drug Labels. Accessed online June 14, 2011 at:
15. Green ED, Guyer MS, and National Human Genome Research Institute. 2011. Charting a course for genomic medicine from base pairs to bedside. Nature 470:204-213.
16. Grosse SD, Khoury MJ. 2006. What is the clinical utility of genetic testing? Genet Med 8:448-450.
17. Guessous I, Gwinn M, Khoury MJ. 2009. Genomewide association studies in pharmacogenomics: an untapped potential for translation. Genome Med 1:46.
18. Gwinn M, Guessous I, Khoury MJ. 2009. Genes, environment and hybrid vigor. Am J Epidemiol 170:703-707.
19. Ho L, van Leeuwen R, Witteman JC, van Duijn CM, Uitterlinden AG, Hofman A, de Jong PT, Vingerling JR, Klaver CC. 2011. Reducing the genetic risk of age-related macular degeneration with dietary antioxidants, zinc, and {omega}-3 fatty acids: The Rotterdam Study. Arch Ophthalmol 129:758-766.
20. HuGE Navigator. 2011. Accessed online June 15, 2011 at:
21. International HapMap Consortium. 2005. A haplotype map of the human genome. Nature 437:1299-1320.
22. International HapMap Consortium. 2007. A second generation human haplotype map of over 3.1 million SNPS. Nature 449:851-861.
23. Ioannidis JP, Bernstein J, Boffetta P, Danesh J, Dolan S, Hartge P, Hunter D, Inskip P, Jarvelin MR, Little J, Maraganore DM, Bishop JA, O'Brien TR, Petersen G, Riboli E, Seminara D, Taioli E, Uitterlinden AG, Vineis P, Winn DM, Salanti G, Higgins JP, Khoury MJ. 2005. A network of investigator networks in human genome epidemiology. Am J Epidemiol 162:302-304.
24. Ioannidis JP, Gwinn M, Little J, Higgins JP, Bernstein JL, Boffetta P, Bondy M, Bray MS, Brenchley PE, Buffler PA, Casas JP, Chokkalingam A, Danesh J, Smith GD, Dolan S, Duncan R, Gruis NA, Hartge P, Hashibe M, Hunter DJ, Jarvelin MR, Malmer B, Maraganore DM, Newton-Bishop JA, O'Brien TR, Petersen G, Riboli E, Salanti G, Seminara D, Smeeth L, Taioli E, Timpson N, Uitterlinden AG, Vineis P, Wareham N, Winn DM, Zimmern R, Khoury MJ; Human Genome Epidemiology Network and the Network of Investigator Networks. 2006. A road map for human genome epidemiology. Nat Genet 38:3-5.
25. Ioannidis JP, Boffetta P, Little J, O'Brien TR, Uitterlinden AG, Vineis P, Balding DJ, Chokkalingam A, Dolan SM, Flanders WD, Higgins JP, McCarthy MI, McDermott DH, Page GP, Rebbeck TR, Seminara D, Khoury MJ. 2008. Evaluation of cumulative evidence on gene-disease associations: interim guidelines. Int J Epidemiol 37:120-132.
26. Ioannidis JP, Tarone R, McLaughlin JK. 2011. The false-positive to false-negative ratio in epidemiologic studies. Epidemiology Apr 12 (pub ahead of print).
27. Janes H, Pepe MS, Bossuyt PM, Barlow WE. 2011. Measuring the performance of makers for guiding treatment decisions. Ann Int Med 154; 253-259.
28. Janssens AC, Khoury MJ. 2010. Assessment of improving prediction beyond traditional risk factors: when does a difference make a difference? Circ Cardiovas Genet 3:3-5.
29. Janssens AC, Ioannidis JP, van Dujin CM, Little J, Khoury MJ for the GRIPS Working Group. 2011. Strengthening the reporting of genetic risk prediction studies: the GRIPS statement. Ann Intern Med. 154:421-425.
30. Khoury MJ, Dorman JS. 1998. The human genome epidemiology network. Am J Epidemiol 148:1-3.
31. Khoury MJ, Beaty TH, Cohen BH. 1993. Fundamentals of Genetic Epidemiology. New York, NY: Oxford University Press.
32. Khoury MJ, Little J, Burke W (eds). 2004. Human Genome Epidemiology: A Scientific Foundation for Using Genetic Information to Improve Health and Prevent Disease. New York, NY: Oxford University Press.
33. st century medicine. Genet Med 11:707-711.
34. Khoury MJ, Bertram L, Boffetta L, Butterworth AS, Chanock SJ, Dolan SM, Fortier I, Garcia-Closas M, Gwinn M, Higgins JPT, Janssens ACJW, Ostell J, Owen RP, Pagon RA, Rebbeck TR, Rothman N, Bernstein JL, Burton PR, Campbell H, Chockalingam A, Furberg H, Little J, O'Brien TR, Seminara D, Vineis P, Winn DM, Yu W, Ioannidis JPA. 2009b. Genome-wide association studies, field synopses and the development of the knowledge base on genetic variation and human diseases. Am J Epidemiol 170:269-279.
35. Khoury MJ, Bedrosian S, Gwinn M, Higgins J, Ioannidis JP, Little J, editors. 2010a. Human Genome Epidemiology: Building the Evidence Base for Using Genetic Information to Improve Health and Prevent Disease, 2nd edition. New York, NY: Oxford University Press.
36. Khoury MJ, Gwinn M, Ioannidis JP. 2010b. The emergence of translational epidemiology: from scientific discovery to population health impact. Am J Epidemiol 172: 517-524.
37. Klein ML, Francis PJ, Rosner B, Reynolds R, Hamon SC, Schultz DW, Ott J, Seddon JM. 2008. CFH and LOC387715/ARMS2 genotypes and treatment with antioxidants and zinc for age-related macular degeneration. Ophthalmology 115:1019-1025.
38. Klein R, Klein BE, Linton KL. 1992. Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology 99:933-943.
39. Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, Haynes C, Henning AK, SanGiovanni JP, Mane SM, Mayne ST, Bracken MB, Ferris FL, Ott J, Barnstable C, Hoh J. 2005. Complement factor H polymorphism in age-related macular degeneration. Science 308:385-389.
40. Kraft P, Hunter DJ. 2005. Integrating epidemiology and genetic association: the challenge of gene-environment interaction. Philos Trans R Soc Lond B Biol Sci 360:1609-1616.
41. Kraft P, Wacholder S, Cornelis MC, Hu FB, Hayes RB, Thomas G, Hoover R, Hunter DJ, Chanock S. 2009. Beyond odds ratios- communicating disease risk based on genetic profiles. Nat Rev Genet 10:264-269.
42. Little J, Higgins JP, Ioannidis JP, Moher D, Gagnon F, von Elm E, Khoury MJ, Cohen B, Davey-Smith G, Grimshaw J, Scheet P, Gwinn M, Williamson RE, Zou GY, Hutchings K, Johnson CY, Tait V, Wiens M, Golding J, van Duijn C, McLaughlin J, Paterson A, Wells G, Fortier I, Freedman M, Zecevic M, King R, Infante-Rivard C, Stewart A, Birkett N. 2009. STrengthening the REporting of Genetic Association studies (STREGA). Genet Epidemiol 33:581-598.
43. Manolio TA. 2010. Genomewide association studies and assessment of the risk of disease. N Engl J Med 363: 166-176.
44. McCarthy MI, Abecasis GR, Cardon KR, Goldstein DB, Little J, Ioannidis JP, Hirchhorn JN. 2008. Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat Rev Genet 9:356-369.
45. Morton NE. 1978. Genetic Epidemiology. London, UK: Academic Press.
46. Mukherjee B, Ahn J, Gruber SB, Ghosh M, Chatterjee N. 2010. Case-control studies of gene-environment interaction: Bayesian design and analysis. Biometrics 66:934-948.
47. Palomaki GE, Melillo S, Neveux L, Douglas MP, Dotson WD, Janssens AC, Balkite EA, Bradley LA. 2010. Use of genomic profiling to assess risk for cardiovascular disease and identify individualized prevention strategies: a targeted evidence-based review. Genet Med 12:772-784.
48. Pepe MS, Janes H. 2011. Commentary: reporting standards are needed for evaluations of risk reclassification. Int J Epidemiol May 13 (ahead of print).
49. Schaumberg DA, Hankinson SE, Guo Q, Rimm E, Hunter DJ. 2007. A prospective study of 2 major age-related macular degeneration susceptibility alleles and interactions with modifiable risk factors. Arch Ophthalmol 125:55-62.
50. Seddon JM, Francis PJ, George S, Schultz DW, Rosner B, Klein ML. 2007. Association of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration. JAMA 297:1793-1800.
51. Seddon JM, Reynolds R, Maller J, Fagerness JA, Daly MJ, Rosner B. 2009. Prediction model for prevalence and incidence of advanced age-related macular degeneration based on genetic, demographic, and environmental variables. Invest Ophthalmol Vis Sci 50:2044-2053.
52. Seminara D, Khoury MJ, O'Brien TR, Manolio T, Gwinn ML, Little J, Higgins JP, Bernstein JL, Boffetta P, Bondy M, Bray MS, Brenchley PE, Buffler PA, Casas JP, Chokkalingam AP, Danesh J, Davey Smith G, Dolan S, Duncan R, Gruis NA, Hashibe M, Hunter D, Jarvelin MR, Malmer B, Maraganore DM, Newton-Bishop JA, Riboli E, Salanti G, Taioli E, Timpson N, Uitterlinden AG, Vineis P, Wareham N, Winn DM, Zimmern R, Ioannidis JP; Human Genome Epidemiology Network; Network of Investigator Networks. 2007. The emergence of networks in human genome epidemiology: challenges and opportunities. Epidemiology 18:1-8.
53. Smith W, Assink J, Klein R, Mitchell P, Klaver CC, Klein BE, Hofman A, Jensen S, Wang JJ, de Jong PT. 2001. Risk factors for age-related macular degeneration: pooled findings from three continents. Ophthalmology 108:697-704.
54. Spencer KL, Olson LM, Schnetz-Boutaud N, Gallins P, Agarwal A, Iannaccone A, Kritchevsky SB, Garcia M, Nalls MA, Newman AB, Scott WK, Pericak-Vance MA, Haines JL. 2011. Using genetic variation and environmental risk factor data to identify individuals at high risk for age-related macular degeneration. PLoS One 6:e17784.
55. Swaroop A, Chew EY, Rickman CB, Abecasis GR. 2009. Unraveling a multifactorial late-onset disease: from genetic susceptibility to disease mechanisms for age-related macular degeneration. Ann Rev Genom Hum Genet 10:19-43.
56. Teutsch SM, Bradley LA, Palomaki GE, Haddow JE, Piper M, Calonge N, Dotson WD, Douglas MP, Berg AO; EGAPP Working Group. 2009. The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) initiative: methods of the EGAPP Working Group. Genet Med 11:3-14.
57. Thakkinstian A, Bowe S, McEvoy M, Smith W, Attia J. 2006. Association between apolipoprotein E polymorphisms and age-related macular degeneration: a HuGE review and meta-analysis. Am J Epidemiol. 164:813-822. PMID: 16916985.
58. Thomas DC. 2000. Genetic epidemiology with a capital E. Genet Epidemiol 19:289-300.
59. Thomas DC. 2010a. Gene-environment wide association studies: emerging approaches. Nat Rev Genet 11:259-272.
60. Thomas DC. 2010b. Methods for investigating gene-environment interactions in candidate pathways and genomewide association studies. Ann Rev Publ Health 31:21-36.
61. Woolf SH. 2008. The meaning of translational research and why it matters. JAMA 299:211-213.
62. Yu W, Gwinn M, Clyne M, Yesupriya A, Khoury MJ. 2008a. A navigator for human genome epidemiology. Nat Genet 40:124-125.
63. Yu W, Clyne M, Dolan SM, Yesupriya A, Wulf A, Liu, Khoury MJ, Gwinn M. 2008b. GAPscreener: an automatic tool for screening human genetic association literature in Pubmed using the support vector machine method. BMC Bioinformatics 9:205 doi: 10.1186/1471-2105-9-205.
64. Yu W, Wulf A, Yesupriya A, Clyne M, Khoury MJ, Gwinn M. 2008c. HuGE watch: tracking trends and patterns of published studies of genetic associations and human genome epidemiology in near-real time. Eur J Hum Genet May 14(eprint);PMID 18478035
65. Yu W, Clyne M, Khoury MJ, Gwinn M. 2010. Phenopedia and genopedia: disease-centered and gene-centered views of the evolving knowledge of human genetic associations. Bioinformatics 26:145-147.
66. Yu W, Yesupriya A, Wulf A, Hindorff LA, Dowling N, Khoury MJ, Gwinn M. 2011. GWAS integrator: a bioinformatics tool to explore human genetic associations reported in published genomewide association studies. Eur J Hum Genet 2011 (epub-ahead of print).
67. Zhang J, Chiodini R, Badr A, Zhang G. 2011. The impact of next generation sequencing on genomics. J Genet Genom 38:95-109.